Anil K Giri

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Venues

Expert opinion on drug discovery

Science advances

PLoS computational biology

Nature communications

Jawaharlal Nehru University

Institute of Genomics and Integrative Biology CSIR (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Jawaharlal Nehru University

India

Trainee :: School of Life sciences

Institute for Molecular Medicine Finland Apr 18 2017

Finland

Post doctoral resercher :: Computational systems medicine

Institute of Genomics and Integrative Biology CSIR Sep 20 2011 - Mar 31 2017

India

PhD resercher :: Genomics and Molecular Medicine

Education History

Institute of Genomics and Integrative Biology CSIR Sep 20 2011 - Mar 31 2017

India

PHD :: Genomics and Molecular Medicine

Publications

Jana von Jan, Sanna Timonen, Till Braun, Qu Jiang, Aleksandr Ianevski, Yayi Peng, Kathleen McConnell, Paola Sindaco, Tony Andreas Müller, Sabine Pützer, Hanna Klepzig, Dennis Jungherz, Annika Dechow, Linus Wahnschaffe, Anil K Giri, Matti Kankainen, Heikki Kuusanmäki, Heidi A Neubauer, Richard H Moriggl, Paolo Mazzeo, Nicole Schmidt, Raphael Koch, Michael J Hallek, Amel Chebel, David Armisen, Laurent Genestier, Emmanuel Bachy, Anjali Mishra, Alexandra Schrader, Tero Aittokallio, Mohamed El Missiry, Marco Herling
Optimizing Drug Combinations for T-PLL: Restoring DNA Damage and P53-Mediated Apoptotic Responses. Blood (2024)
Aleksandr Ianevski, Anil K Giri, Tero Aittokallio
Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data. Nature communications 13 (1) (2022)
Aleksandr Ianevski, Jenni Lahtela, Komal K Javarappa, Philipp Sergeev, Bishwa R Ghimire, Prson Gautam, Markus Vähä-Koskela, Laura Turunen, Nora Linnavirta, Heikki Kuusanmäki, Mika Kontro, Kimmo Porkka, Caroline A Heckman, Pirkko Mattila, Krister Wennerberg, Anil K Giri, Tero Aittokallio
Patient-tailored design for selective co-inhibition of leukemic cell subpopulations. Science advances 7 (8) (2021)
Anil K Giri, Aleksander Ianevski
High-throughput screening for drug discovery targeting the cancer cell-microenvironment interactions in hematological cancers. Expert opinion on drug discovery (2021)
Aleksandr Ianevski, Sanna Timonen, Alexander Kononov, Tero Aittokallio, Anil K Giri
SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy. PLoS computational biology 16 (2) (2020)

Anil K Giri.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anil K Giri